Skip to main content
Log in

Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer

  • Originals
  • Published:
Urological Research Aims and scope Submit manuscript

Summary

Serum amyloid A (SAA) and acid phosphatase (AcP) levels were determined in serial serum samples of 35 patients in different stages of dissemination and correlated with activity of carcinoma of the prostate. Up to 500-fold increases in SAA level were detected during active periods of cancer with a decrease towards the normal range in remission, in comparison with a 10-fold increase of AcP. The correlation between these two parameters was highly significant (P<0.001), but while SAA shows 100% sensivity during the active stage, AcP shows only 85% sensitivity. It is suggested that althouth SAA is not a specific marker for any particular illness, due to its characteristic pattern of change in malignant diseases and its high sensitivity, it represents a useful biochemical parameter for the assessment of the activity of the disease to monitor response to therapy during follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baumal R, Sklar S, Wilson B, Laskov R (1978) Casein-induced murine amyloidosis: amyloidogenesis in vitro by monolayer spleen explants of casein-infected mice. Lab Invest 36:632

    Google Scholar 

  2. Bausserman LL, Herbert PN, McAdam KRWJ (1980) Heterogeneity of human serum amyloid A protein. J Exp Med 152:641

    Google Scholar 

  3. Benditt EP, Erikson N (1977) Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 74:4025

    Google Scholar 

  4. Benson MD, Aldo-Benson M (1979) Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol 122:2077

    Google Scholar 

  5. Benson MD, Kleiner E (1980) Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol 124:495

    Google Scholar 

  6. Bruce AW, Mahan DE, Morales A, Clark AF, Belville WD (1979) An objective look at acid phosphatase determinations. Br J Urol 51:213

    Google Scholar 

  7. Catalona WJ, Menon M (1981) New screening and diagnostic tests for prostate cancer and immunologic assessment. Urology (Suppl) 17:61

    Google Scholar 

  8. Fair WR, Catalona WJ, Ratliff TR, Hector WDW (1980) Tumor markers for prostatic carcinoma: PAP and CK-BB. Presented at the Annual Meeting American Urological Assoc. San Francisco, Cal

  9. Fair WR, Kadmon D (1983) Carcinoma of the prostate: Diagnosis and staging. Current status and future prospects. World J Urol 1:3

    Google Scholar 

  10. Gutman AB, Gutman EB (1938) An “acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest 17:473

    Google Scholar 

  11. Hennebery MD, Engel G, Grayhack JT (1979) Acid Phosphatase. Urol Clin North Am 6:629

    Google Scholar 

  12. Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:945

    Google Scholar 

  13. Kushner I (1982) The phenomenon of the acute phase response. In: Volanakis JE, Geverz H (eds) Annals of the NY Academy of Science, Vol 389, p39

  14. Levin M, Pras M, Franklin EC (1973) Immunologic studies of the major non-immunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J Exp Med 138:373

    Google Scholar 

  15. Linder E, Lehto VP, Vintanen I, Stenman J, Natvig JB (1977) Localization of amyloid related serum protein SAA-like material to intermediate filaments of cultured human embryonal fibroblasts. J Exp Med 146:1158

    Google Scholar 

  16. Pontes JE (1981) New assays for prostatic acid phosphatase and alkaline phosphatase isoenzymes. Urology (Suppl) 17:38

    Google Scholar 

  17. Rosenthal CJ, Franklin EC (1975) Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest 55:746

    Google Scholar 

  18. Rosenthal CJ, Sullivan L (1978) Serum amyloid A. Evidence for its origin in polymorphonuclear leukocytes. J Clin Invest 62:1181

    Google Scholar 

  19. Rosenthal CJ, Sullivan LM (1979) Serum amyloid A to monitor cancer dissemination. Ann Int Med 91:383

    Google Scholar 

  20. Sarov I, Shainkin-Kestenbaum R, Zimlichman S, Winikoff Y, Chaimovitz C, Pras M (1982) Serum amyloid A levels in patients with infection. J Infect Dis 146:443

    Google Scholar 

  21. Selinger MJ, McAdam KRWJ, Kaplan MM, Sipe JD, Vogen SN, Rosenstreich DL (1980) Monokine induced synthesis of serum amyloid A protein by hepatocytes. Nature 285:498

    Google Scholar 

  22. Shainkin-Kestenbaum R, Zimlichman S, Winikoff Y, Pras M, Chaimovitz C, Sarov I (1982) Serum amyloid A in viral infection. Clin Exp Immunol 50:503

    Google Scholar 

  23. Sipe JD, Vogel SN, Ryan JL, McAdam KRWJ, Rosenstreich DL (1979) Detection of a mediator derived from endotoxinstimulated macrophages that induced the acute phase serum amyloid A response in mice. J Exp Med 150:597

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The work was supported by a grant from the Israel Academy of Science-Basic Research

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaneti, J., Winikoff, Y., Zimlichman, S. et al. Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer. Urol. Res. 12, 239–241 (1984). https://doi.org/10.1007/BF00256147

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00256147

Key words

Navigation